"Receptors, CXCR3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
CXCR receptors that are expressed on the surface of a number of cell types, including T-LYMPHOCYTES; NK CELLS; DENDRITIC CELLS; and a subset of B-LYMPHOCYTES. The receptors are activated by CHEMOKINE CXCL9; CHEMOKINE CXCL10; and CHEMOKINE CXCL11.
Descriptor ID |
D054367
|
MeSH Number(s) |
D12.776.543.750.695.160.500.300 D12.776.543.750.705.852.125.500.300
|
Concept/Terms |
Receptors, CXCR3- Receptors, CXCR3
- CXCR3 Receptor
- Receptor, CXCR3
- CXC Chemokine Receptor 3
- CD183 Antigens
- Antigens, CD183
- CXCR3 Receptors
- Chemokine (C-C Motif) Receptor 3
- CMKBR3 Chemokine Receptors
- Chemokine Receptors, CMKBR3
- Receptors, CMKBR3 Chemokine
- CXC Chemokine Receptors 3
|
Below are MeSH descriptors whose meaning is more general than "Receptors, CXCR3".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Chemokine [D12.776.543.750.695.160]
- Receptors, CXCR [D12.776.543.750.695.160.500]
- Receptors, CXCR3 [D12.776.543.750.695.160.500.300]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Chemokine [D12.776.543.750.705.852.125]
- Receptors, CXCR [D12.776.543.750.705.852.125.500]
- Receptors, CXCR3 [D12.776.543.750.705.852.125.500.300]
Below are MeSH descriptors whose meaning is more specific than "Receptors, CXCR3".
This graph shows the total number of publications written about "Receptors, CXCR3" by people in this website by year, and whether "Receptors, CXCR3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2012 | 1 | 1 | 2 |
2015 | 0 | 1 | 1 |
2017 | 1 | 7 | 8 |
2018 | 3 | 4 | 7 |
2019 | 3 | 0 | 3 |
2020 | 0 | 2 | 2 |
2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, CXCR3" by people in Profiles.
-
CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2-infected patients. JCI Insight. 2021 09 22; 6(18).
-
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021 03 16; 2(3):100208.
-
Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals. Nat Microbiol. 2021 01; 6(1):51-58.
-
MAIT cell activation and dynamics associated with COVID-19 disease severity. Sci Immunol. 2020 09 28; 5(51).
-
Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon ? and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection. J Infect Dis. 2019 07 31; 220(5):830-840.
-
The role of CXCR3 and its ligands CXCL10 and CXCL11 in the pathogenesis of celiac disease. Medicine (Baltimore). 2019 Jun; 98(25):e15949.
-
Impaired Th17 cell proliferation and decreased pro-inflammatory cytokine production in CXCR3/CXCR4 double-deficient mice of vulvovaginal candidiasis. J Cell Physiol. 2019 08; 234(8):13894-13905.
-
Memory formation and long-term maintenance of IL-7Ra+ ILC1s via a lymph node-liver axis. Nat Commun. 2018 11 19; 9(1):4854.
-
Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease. Viral Immunol. 2019 Jan/Feb; 32(1):25-37.
-
The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4+ T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway. Vaccine. 2018 06 14; 36(25):3650-3665.